Veronica Visit 1: 57-year-old African American female with 9-year history of type 2 diabetes and newly diagnosed albuminuria

Title:

Veronica Visit 1: 57-year-old African American female with 9-year history of type 2 diabetes and newly diagnosed albuminuria

Topic: Nephrology
Relevant Terms: Chronic Kidney Disease, Diabetes, Diabetic Nephropathy, Primary Care
Primary Audience: Endocrinologists, internal medicine physicians, Nephrologists, Primary Care Physicians
Launch Date: 22-Oct-12
Credits: 0.5 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Diabetic Nephropathy in Clinical Practice: Preventing Progression to Chronic Kidney Disease...

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Recognize the clinical significance of microalbuminuria in type 2 diabetic patients.
  2. Outline existing and emerging therapeutic strategies which delay progression to CKD.
  3. Implement strategies for patient compliance and adherence to renal treatment plans.
  4. Apply best strategies for patient care based upon duration and control of diabetes, urinary protein, and kidney function, and patient compliance.

    Faculty

    Mohamed G. Atta, MD, MPH
    Associate Professor of Medicine
    Johns Hopkins University School of Medicine
    Medical Director of the Dialysis Center, DaVita Health Care
    Baltimore, MD
    Ajay K. Singh, MD
    Director, Continuing Medical Education, Department of Medicine and Renal Division
    Brigham and Women's Hospital
    Associate Professor
    Harvard Medical School
    Boston, MA
    Jeffrey R. Unger, MD
    Associate Clinical Professor of Family Medicine
    Loma Linda University School of Medicine
    Director, Metabolic Studies
    Catalina Research Institute
    Chino, CA
    Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of continuing education (CE) activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
     
    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
    • Mohamed G. Atta, MD, MPH, has no affiliations with commercial interests to disclose.
    • Ajay K. Singh, MD, has affiliations with HIS Dialysis and Sandoz (Consulting Fees).
    • Jeffrey R. Unger, MD, has affiliations with Lippincott Publishing (Diabetes Management in Primary Care - 2nd ed), Spry Publishing, Diabetes For The Disinterested (Royalty); Abbott Pharmaceuticals, Lifescan, and Halodyne, Inc. (Consulting Fees); Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Merck, and Sanofi Aventis (Contracted Research).
    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
    RMEI, LLC
    • Alisa G. Woods, PhD, has no affiliations with commercial interests to disclose.
    • Cindy Kunzer has no affiliations with commercial interests to disclose.
    Postgraduate Institute for Medicine
    • Laura Excell, ND, NP, MS, MA, LPC, NCC, has no affiliations with commercial interests to disclose.
    • Trace Hutchison, PharmD, has no affiliations with commercial interests to disclose.
    • Samantha Mattiucci, PharmD, has no affiliations with commercial interests to disclose.
    • Jan Schultz, RN, MSN, CCMEP, has no affiliations with commercial interests to disclose.
    • Patricia Staples, MSN, NP-C, CCRN, has no affiliations with commercial interests to disclose.
       
    Disclaimer
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
     
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), RMEI, LLC, and Abbott Laboratories do not recommend the use of any agent outside of the labeled  indications.The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, RMEI, or Abbott Laboratories. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    PHYSICIAN CONTINUING EDUCATION
    ACCREDITATION STATEMENT
    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and RMEI, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    CREDIT DESIGNATION
    The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    FEE INFORMATION
    There is no fee for this educational activity.

    COMMERCIAL SUPPORT
    This activity is jointly sponsored/co-provided by RMEI, LLC and Postgraduate Institute for Medicine. RMEI gratefully acknowledges an educational grant from Abbott Laboratories in support of this CME activity.

    HOW TO RECEIVE CREDIT
    By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 0.50 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page.
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit. You must score with a 65% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

    COURSE VIEWING REQUIREMENTS
    Google Chrome for Windows, Mac, or Linux
    Internet Explorer 7.0+ for Windows
    Mozilla 1.4+ for Windows, Mac, or Linux
    Firefox 3.5+ for Windows, Mac, or Linux
    Safari 4.0+ for Mac